Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use) < Antiparkinson Agents (toxicity)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 225.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000012 (1999)	L. Defebvre [France] ; P. Derambure ; J L Bourriez ; A. Destée ; J D Guieu	[Event-related desynchronization and Parkinson disease. Importance in the analysis of the phase of preparation for movement].
000013 (1998)		Ropinirole: new preparation. Wait for more convincing data.
000020 (1999)	B P Bejjani [France] ; P. Damier ; I. Arnulf ; L. Thivard ; A M Bonnet ; D. Dormont ; P. Cornu ; B. Pidoux ; Y. Samson ; Yves Agid [France]	Transient acute depression induced by high-frequency deep-brain stimulation.
000042 (1999)	C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. Rascol	Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
000047 (????)	H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L Montastruc	A study of salivary secretion in Parkinson's disease.
000073 (1999)	M. Gentil [France] ; C L Tournier ; P. Pollak ; A L Benabid	Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
000074 (1999)	S. Champagne [France] ; E. Coste ; H. Peyrière ; J. Nigond ; E. Mania ; M. Pons ; D. Hillaire-Buys ; P. Balmes ; J P Blayac ; J M Davy	Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
000085 (1999)	L. Vercueil [France] ; J P Linard ; B. Wuyam ; P. Pollak ; G. Benchetrit	Breathing pattern in patients with Parkinson's disease.
000099 (????)		[Parkinson disease].
000102 (2000)	B P Bejjani [France] ; D. Dormont ; B. Pidoux ; J. Yelnik ; P. Damier ; I. Arnulf ; A M Bonnet ; C. Marsault ; Yves Agid [France] ; J. Philippon ; P. Cornu	Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
000105 (2000)	B. Bejjani ; D. Gervais ; I. Arnulf ; S. Papadopoulos ; S. Demeret ; A. Bonnet ; P. Cornu ; P. Damier ; Yves Agid [France]	Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation
000108 (2000)	S. Meunier [France] ; S. Pol ; J L Houeto ; M. Vidailhet	Abnormal reciprocal inhibition between antagonist muscles in Parkinson's disease.
000116 (2000)	O. Rascol [France] ; D J Brooks ; A D Korczyn ; P P De Deyn ; C E Clarke ; A E Lang	A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
000121 (2000)	P. Krack [France] ; P L Dowsey ; A L Benabid ; N. Acarin ; A. Benazzouz ; G. Künig ; K L Leenders ; J A Obeso ; P. Pollak	Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism.
000127 (2000)	O. Rascol [France] ; J L Montastruc	[Role of dopaminergic agonists].
000160 (2001)	L. Pezard [France] ; R. Jech ; E. Růzicka	Investigation of non-linear properties of multichannel EEG in the early stages of Parkinson's disease.
000163 (2001)	O. Rascol [France] ; J G Nutt ; O. Blin ; C G Goetz ; J M Trugman ; C. Soubrouillard ; J H Carter ; L J Currie ; N. Fabre ; C. Thalamas ; W W Giardina ; S. Wright	Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
000183 (2001)	O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L Montastruc	The pharmacologic treatment of gait ignition failure.
000191 (2001)	J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
000199 (2000)		Pergolide and Parkinson's disease: new preparation. No clear benefit.
000200 (2001)	O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]	Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024